Aurinia Pharmaceuticals Reaches Analyst Target Price
November 01, 2021 at 09:07 AM EDT
In recent trading, shares of Aurinia Pharmaceuticals Inc (AUPH) have crossed above the average analyst 12-month target price of $32.00, changing hands for $33.08/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..